See More Hear More Watch More Hear More Get on iTunes
WSJ Daily Minute WSJMinute

Actavis nearing deal to buy Allergan

Actavis is nearing a deal to acquire Allergan that could swipe the Botox maker from hostile suitor Valeant. The boards of the two companies are expected to meet in the coming days to review a cash-and-stock takeover.


More from